96 related articles for article (PubMed ID: 20973900)
1. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
Fong AW; Lee GA; O'Rourke P; Thomas R
Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Results of Transscleral Diode Laser Cyclophotocoagulation in Glaucoma: A Real-Life Study.
Sari C; Alagoz N; Omeroglu A; Cakir I; Pasaoglu I; Altan C; Yasar T
J Glaucoma; 2024 Jun; 33(6):437-443. PubMed ID: 38129950
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for neovascular glaucoma.
Vasudev D; Blair MP; Galasso J; Kapur R; Vajaranant T
J Ocul Pharmacol Ther; 2009 Oct; 25(5):453-8. PubMed ID: 19857107
[TBL] [Abstract][Full Text] [Related]
4. Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma - a retrospective interventional case series.
Strzalkowski P; Strzalkowska A; Göbel W; Loewen NA; Hillenkamp J
F1000Res; 2020; 9():1236. PubMed ID: 33796275
[No Abstract] [Full Text] [Related]
5. The effect of cumulative energy in repeated subliminal transscleral cyclophotocoagulation: a retrospective study.
Szabó Á; Árpádffy-Lovas T; Hagyó K; Cseke I; Vámosi P; Tóth-Molnár E
BMC Ophthalmol; 2024 Jun; 24(1):233. PubMed ID: 38831268
[TBL] [Abstract][Full Text] [Related]
6. Primary Transscleral Diode Laser Cyclophotocoagulation for Management of Glaucoma in Nanophthalmic Eyes.
Abdelrahman AM; Ismail YM
J Glaucoma; 2024 Apr; 33(4):e15-e18. PubMed ID: 37585376
[TBL] [Abstract][Full Text] [Related]
7. The outcomes of diode laser transscleral cyclophotocoagulation in refractory primary angle-closure glaucoma in a South Indian population.
Raja V; Balasubramaniam N; Sundar B; Nagdev N
Indian J Ophthalmol; 2024 Mar; 72(3):397-401. PubMed ID: 38099577
[TBL] [Abstract][Full Text] [Related]
8. Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma.
Kingston EJ; Lusthaus JA
Int Ophthalmol; 2023 Aug; 43(8):2763-2776. PubMed ID: 36913166
[TBL] [Abstract][Full Text] [Related]
9. Does Bevacizumab Improve Outcomes After Ahmed Glaucoma Valve Implantation for Refractory Glaucoma?: A Meta-Analysis.
Tran L; Vo J; Bell K; Perera S; Crowston J
J Glaucoma; 2024 Jun; 33(6):444-455. PubMed ID: 38194278
[TBL] [Abstract][Full Text] [Related]
10. Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation.
Hadjokas N; Dosakayala N; Alpert S; Ganapathy P; Fechtner R
Lasers Med Sci; 2024 May; 39(1):136. PubMed ID: 38795228
[TBL] [Abstract][Full Text] [Related]
11. [Clinical outcomes of laser activation of hydraulic permeability of the sclera in the treatment of advanced glaucoma].
Yusef YN; Gamidov AA; Gavrilina PD; Baum OI
Vestn Oftalmol; 2023; 139(6):19-25. PubMed ID: 38235626
[TBL] [Abstract][Full Text] [Related]
12. Controlled Cyclophotocoagulation with diode laser in refractory glaucoma and long term follow up at King Abdulaziz University Hospital, Riyadh.
Osman EA; Al-Muammar A; Mousa A; Al-Mezaine H; Al-Obeidan SA
Saudi J Ophthalmol; 2010 Jan; 24(1):9-13. PubMed ID: 23960867
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a novel low-cost torchlight transcorneal transillumination for diode laser transscleral cyclophotocoagulation in adult glaucoma.
Thattaruthody F; Chauhan N; Choudhary S; Raj S; Pandav SS; Kaushik S
Eur J Ophthalmol; 2024 May; ():11206721241253305. PubMed ID: 38710194
[TBL] [Abstract][Full Text] [Related]
14. Improving Outcomes in Neovascular Glaucoma.
Qiu M; Shukla AG; Sun CQ
Ophthalmol Glaucoma; 2022; 5(2):125-127. PubMed ID: 35031284
[No Abstract] [Full Text] [Related]
15. In vivo measurement of the attenuation coefficient of the sclera and ciliary muscle.
Monterano Mesquita G; Patel D; Chang YC; Cabot F; Ruggeri M; Yoo SH; Ho A; Parel JA; Manns F
Biomed Opt Express; 2021 Aug; 12(8):5089-5106. PubMed ID: 34513244
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results.
Jammal AA; Costa DC; Vasconcellos JPC; Costa VP
Arq Bras Oftalmol; 2019 Jun; 82(5):381-388. PubMed ID: 31271570
[TBL] [Abstract][Full Text] [Related]
17. Quantitative systems pharmacology of the eye: Tools and data for ocular QSP.
Kuepfer L; Fuellen G; Stahnke T
CPT Pharmacometrics Syst Pharmacol; 2023 Mar; 12(3):288-299. PubMed ID: 36708082
[TBL] [Abstract][Full Text] [Related]
18. Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma.
Zemba M; Dumitrescu OM; Vaida F; Dimirache EA; Pistolea I; Stamate AC; Burcea M; Branisteanu DC; Balta F; Barac IR
Exp Ther Med; 2022 Apr; 23(4):278. PubMed ID: 35317447
[TBL] [Abstract][Full Text] [Related]
19. Triple Procedure for Dense Cataractous Neovascular Glaucoma Patients.
Moharram HM; Abd-Elhamid Mehany Elwan S; Nassar MM; Abdelkader MF
J Ophthalmol; 2020; 2020():1251203. PubMed ID: 32655940
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
